• The Janssen vaccines to be delivered by the US government will help reactivate the economy, trade and tourism at the border.
• Mexico ranked sixth in the world in administering COVID-19 vaccines from May 31-June 6.
During this morning's press conference led by President Andrés Manuel López Obrador, Foreign Secretary Marcelo Ebrard gave an update on Mexico's COVID-19 vaccine supply strategy, underscoring that, from May 31-June 6, Mexico was sixth in the world in administering the highest number of doses.
The Foreign Secretary said that, to date, Mexico has received or fill-finished 43,347,665 doses of vaccines. From June 1-7, 3,458,990 doses of Pfizer arrived in our country, comprised of 1,458,990 doses from Pfizer; one million doses of Sinovac and Sputnik, and a million doses as a bulk shipment from CanSinoBio to be fill-finished nationally.
Secretary Ebrard said that, on June 3, U.S. Vice President Kamala Harris informed President López Obrador that, as a gesture of solidarity and support for Mexico, the United States government would deliver over one million doses of the Janssen vaccine. This vaccine will be the sixth to join the Mexican portfolio. On the instructions of the President, the doses will be used in the municipalities on the Mexico-U.S. border.
The Mexican government has held talks with Johnson & Johnson and with the regulatory and health authorities in the U.S. and Mexico to finalize the details of the delivery. As was announced recently, these doses will be used to balance or equalize the proportion of vaccinated individuals in the border region, in conjunction with the government's strategy to vaccinate all Mexicans between 18 and 39 years of age in the 38 municipalities that border the U.S. In this way, it will be possible "to reactivate the usual economic activity, trade and tourism in that very important region of the country," said the Secretary.
Lastly, the Foreign Secretary reiterated that the single-dose Johnson & Johnson vaccine received emergency use authorization in Mexico from the Federal Commission for Protection against Health Risks (Cofepris) on May 27. This delivery expands Mexico's vaccine portfolio and accelerates the government's National Vaccination Plan.
The Ministry of Foreign Affairs reaffirms its commitment to conduct a foreign policy that prioritizes the health of the Mexican people, and contributes to universal, timely and equitable access to the COVID-19 vaccine.
